miR-326 Inhibits the Progression of Papillary Thyroid Carcinoma by Targeting MAPK1 and ERBB4

Neoplasma - Slovakia
doi 10.4149/neo_2020_190731n696
Full Text
Abstract

Available in full text

Categories
Cancer Research
Date
Authors
Publisher

AEPress, s.r.o.

Related search

miR-29a Inhibits Proliferation, Invasion, and Migration of Papillary Thyroid Cancer by Targeting DPP4

OncoTargets and Therapy
OncologyPharmacology
2019English

miR-422a Inhibits Cell Proliferation in Colorectal Cancer by Targeting AKT1 and MAPK1

Cancer Cell International
Cancer ResearchOncologyGenetics
2017English

OTUD6B-AS1 Inhibits Viability, Migration, and Invasion of Thyroid Carcinoma by Targeting miR-183-5p and miR-21

Frontiers in Endocrinology
EndocrinologyMetabolismDiabetes
2020English

In Vivo Imaging of Functional Targeting of miR-221 in Papillary Thyroid Carcinoma

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2008English

Long Noncoding RNA ZFAS1 Promotes Progression of Papillary Thyroid Carcinoma by Sponging miR-590-3p and Upregulating HMGA2 Expression

OncoTargets and Therapy
OncologyPharmacology
2019English

MIR-138-5P Inhibits the Progression of Prostate Cancer by Targeting FOXC1

Molecular genetics & genomic medicine
GeneticsMolecular Biology
2020English

MicroRNA‑766 Inhibits Papillary Thyroid Cancer Progression by Directly Targeting Insulin Receptor Substrate 2 and Regulating the PI3K/Akt Pathway

International Journal of Oncology
Cancer ResearchOncology
2018English

Overexpression of miR-101 Promotes TRAIL-induced Mitochondrial Apoptosis in Papillary Thyroid Carcinoma by Targeting C-Met and McL-1

Oncotarget
Oncology
2017English

miR‑99 Inhibits Cervical Carcinoma Cell Proliferation by Targeting TRIB2

Oncology Letters
Cancer ResearchOncology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy